Dr. Reddy`s Laboratories Ltd. - ADR Shares Approach 52-Week High - Market Mover
The shares closed 1.1% below its 52-week high of $73.17, with trading volume higher than its 30 day average
Feb 01, 2024 by Kwhen Finance Editors
Dr. Reddy`s Laboratories Ltd. - ADR (RDY) shares closed today at 1.1% below its 52 week high of $73.17, giving the company a market cap of $11B. The stock is currently up 0.7% year-to-date, up 33.3% over the past 12 months, and up 98.2% over the past five years. This week, the Dow Jones Industrial Average rose 0.9%, and the S&P 500 rose 1.6%.
Trading Activity
- Trading volume this week was 116.3% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.3.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Dr. Reddy`s Laboratories Ltd. - ADR | 0.6 | 0.7 | 33.3 | -2.1 | 39.1 |
| Dow Jones Industrial Average | 1.0 | 1.8 | 15.9 | -0.5 | 24.2 |
| S&P 500 Index | 1.3 | 3.4 | 23.8 | -1.4 | 30.2 |
| Technology Industry | -3.4 | -15.6 | -70.8 | -70.2 | 12.1 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -83.2%
- The company's stock price performance over the past 12 months beats the peer average by 711.1%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Dr. Reddy`s Laboratories Ltd. - ADR | RDY | 0 | 0.7 | 33.3 | -2.1 | 39.1 |
| Peer Avg | N/A | 10.6 | 3.9 | 4.1 | -6.8 | 22.3 |
| Novartis AG - ADR | NVS | 31.4 | 6.9 | 25.9 | -3.5 | 31.8 |
| Pfizer Inc. | PFE | 14.8 | -3.1 | -34.0 | -36.1 | 6.4 |
| Sanofi - ADR | SNY | 14.2 | 1.1 | 3.7 | ||
| Glaxosmithkline plc - ADR | GSK | 9.0 | 5.4 | 15.1 | -1.1 | 23.8 |
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | -6.0 | 13.3 | 14.0 | -0.3 | 71.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: